Literature DB >> 12395312

Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology.

Chien-Jen Chen, Ding-Shinn Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395312     DOI: 10.1053/jhep.2002.37084

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  31 in total

1.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

2.  An indel polymorphism in the 3' untranslated region of JAK1 confers risk for hepatocellular carcinoma possibly by regulating JAK1 transcriptional activity in a Chinese population.

Authors:  Qiang Yu; Weifeng Qian; Jian Wang; Yejiao Wu; Jinkun Zhang; Weichang Chen
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

Review 3.  Hepatocellular carcinoma: therapy and prevention.

Authors:  Hubert E Blum
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

4.  Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.

Authors:  Hui-Chen Wu; Qiao Wang; Lian-Wen Wang; Hwai-I Yang; Habibul Ahsan; Wei-Yann Tsai; Li-Yu Wang; Shu-Yuan Chen; Chien-Jen Chen; Regina M Santella
Journal:  Cancer Lett       Date:  2007-01-23       Impact factor: 8.679

Review 5.  Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review.

Authors:  Fei Jin; Wen-Jian Xiong; Jia-Chen Jing; Zhen Feng; Li-Shuai Qu; Xi-Zhong Shen
Journal:  J Cancer Res Clin Oncol       Date:  2011-01-15       Impact factor: 4.553

6.  Hepatocellular carcinoma risk scores: ready to use in 2015?

Authors:  Chien-Jen Chen; Mei-Hsuan Lee; Jessica Liu; Hwai-I Yang
Journal:  Hepat Oncol       Date:  2015-01-12

7.  Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.

Authors:  Hongxing Zhang; Yun Zhai; Zhibin Hu; Chen Wu; Ji Qian; Weihua Jia; Fuchao Ma; Wenfeng Huang; Lixia Yu; Wei Yue; Zhifu Wang; Peiyao Li; Yang Zhang; Renxiang Liang; Zhongliang Wei; Ying Cui; Weimin Xie; Mi Cai; Xinsen Yu; Yunfei Yuan; Xia Xia; Xiumei Zhang; Hao Yang; Wei Qiu; Jingmin Yang; Feng Gong; Minshan Chen; Hongbing Shen; Dongxin Lin; Yi-Xin Zeng; Fuchu He; Gangqiao Zhou
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

8.  HBV suppresses thapsigargin-induced apoptosis via inhibiting CHOP expression in hepatocellular carcinoma cells.

Authors:  Danqi Zhao; Yan Liu; Xing Liu; Tao Li; Zhenhui Xin; Xilin Zhu; Xiaopan Wu; Ying Liu
Journal:  Oncol Lett       Date:  2017-07-25       Impact factor: 2.967

9.  Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Zhangyong Hu; Zhipeng Zhou; Guolian Xiong; Yali Wang; Yi Lai; Lan Deng; Jinliang Yang
Journal:  Tumour Biol       Date:  2014-02-26

10.  Evolving therapies in the treatment of hepatocellular carcinoma.

Authors:  Hans Christian Spangenberg; Robert Thimme; Hubert E Blum
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.